Drug repurposing in NCDs: benefits and challenges
Date
2021-04
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
BRAC University
Abstract
This review focuses on repurposing of drugs for the treatment of noncommunicable diseases. Drug repurposing is the development of new indications for existing drugs. Noncommunicable diseases are causing large number of deaths every year. Therefore, drug repurposing is an effective strategy for the treatment of noncommunicable diseases. This review discusses the methods, benefits and challenges of drug repurposing as well as all the approved repurposed drugs for NCDs and the repurposed drugs that are awaiting approval by the FDA. Considering the challenges faced due to repurposing of drugs, some recommendations are put forward to improve the future of drug repurposing.
Description
Cataloged from PDF version of thesis report.
Includes bibliographical references (pages 34-49).
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Includes bibliographical references (pages 34-49).
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Keywords
Drug repurposing, Noncommunicable disease, Market and data exclusivity, Benefits and challenges